Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ONLY 1 more?
Why only 1 more?
1 more pump brewing
CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers
HOUSTON, July 01, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is excited to announce the submission of our inaugural pair of patents, focusing on novel treatment methodologies for breast and pancreatic cancers, for legal review and subsequent registration.
Our dedicated scientific team has invested countless hours in research, culminating in the development of innovative treatment approaches specifically designed to tackle breast and pancreatic cancers. These conditions, affecting millions globally, present unique challenges due to their prevalence and the severity of their outcomes. Breast cancer, for instance, impacts approximately one in eight women in the United States over their lifetime, while pancreatic cancer is notorious for its late-stage diagnosis and grim prognosis, with a five-year survival rate below 10%.
Jennifer Salguero, PhD in Science with emphasis on Microbiology, highlights the urgency and strategic focus of our approach: "Given the stark statistics associated with these cancers, our team recognizes the critical need for aggressive yet targeted interventions. Our aim is to not only target the tumors but also safeguard surrounding tissues, leveraging the inherent antitumor properties of cannabinoids."
CBIH aims to accelerate our pace of innovation by submitting an additional 3 to 4 patents per month throughout the remainder of the year. Among our top priorities are patents related to the treatment of herpes zoster, knee osteoarthritis, and Alzheimer's disease, harnessing the antiviral, anti-inflammatory, and neuroprotective benefits of cannabinoids.
To support this goal, we are expanding and strengthening our research team, focusing on patent and formulation development. We are honored to welcome Sheila Tarqui, with a comprehensive background in biology, pharmaceutical chemistry, public health, and dermatic cosmetics, enriched by her education from Ricardo Palma University, María Auxiliadora University, San Juan Bautista Private University (Peru), and Francisco de Vitoria University (Madrid, España), makes her an invaluable addition. We expect Tarqui’s expertise will significantly contribute to advancing our innovation and maintaining our high standards of excellence.
Moreover, we are proactively trying to recruit medical specialists in oncology and cardiology to deepen our exploration of cannabis compounds' therapeutic applications. Despite substantial existing research, cardiovascular diseases persist as the world's leading cause of death, with limited understanding of cannabinoids' potential in this field. Identifying this as an emerging opportunity, we see the combination of cardiovascular medicine and cannabinoid research as a promising path for developing innovative treatments. Our recruitment efforts aim to fill this knowledge gap and unlock new possibilities for addressing prevalent and life-threatening conditions worldwide.
"These strategies contribute to securing and protecting our intellectual property which is paramount. By harnessing cutting-edge therapies, artificial intelligence, and advanced biotechnological techniques, we aim to safeguard and successfully market our groundbreaking medical advancements" says Rosangel Andrades, Research and Development Department Director.
We remain steadfast in our mission to leverage the full potential of cannabinoids to improve patient outcomes and contribute to global health initiatives. At CBIH, we are redefining medicine and treatment strategies.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties, and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file at www.OTCmarkets.com.
For more information contact us at:
(214) 733-0868
ir@cbih.net
Dante Picazo
CEO - CBIH
Website: www.cbih.net
X: www.twitter.com/cbihstock
Instagram: www.instagram.com/CBIHSTOCK
Investor Relations:
East Coast
Peter Nicosia
Bull in Advantage, LLC
Phone: 585-703-6565
Email: Info@BlueHorseshoeStocks.com
West Coast
Zach Logan
Pacific Capital Markets LLC
Phone: 858.864.0011
Email: pacificcapitalmarketsllc@gmail.com
https://www.globenewswire.com/newsroom/ti?nf=OTE3MTQzNCM2MzQ4NzkyIzIyOTIzMDQ=
https://ml.globenewswire.com/media/NjJhZDk4NzYtYmVhMy00ODZhLTk5NTQtNGQ2OTIyOTRkYTA2LTEzMDM4NTQ=/tiny/CANNABIS-BIOSCIENCE-INTERNATIO.png
Source: CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
© 2024 GlobeNewswire, Inc.
https://www.otcmarkets.com/stock/CBIH/news/story?e&id=2905906
u sell for loss
CBIH's Recently Appointed Director Unveils Groundbreaking Product Strategies and Potential Partnership with Industry Leader
— CBIH (@CBIHstock) June 24, 2024
As CBIH prepares for the manufacturing and distribution of its products, the potential collaboration might involve this entity acting as CBIH's product…
Basing around .0011? But it's worth BILLIONS.lol
With the latest news shareprize estimation around $0,20 p.s.
$CBIH Bought some here for a Momentum runner here. $2 Billion News evaluation with Mark Cubans brother on the board.
$CBIH Bought some here for a Momentum runner here. $2 Billion News evaluation with Mark Cubans brother on the board.
At 18's now, the HOD, way undervalued and market seems to be sleeping on it, word is slowly spreading though
$CBIH$$$$ AT .0013 VALUE IS ONLY $14.3MILLION A FAR CRY
FROM $2BILLION VALUE THAT REPORT SUGGESTS.
https://www.otcmarkets.com/stock/CBIH/security
MY MATH SAYS .181818
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174610441
IDK, but the chart was telling me a breakout over 8's was imminent, see my post a couple weeks ago, chart said to me something was stirring and now today the breakout on the news, charts forcast news events, proven here.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174546410
The only way “the chart” would know is if someone knew news was coming…
Unless that’s exactly what you are referring too?
Yeah, the chart saw it coming, that's why I bought, from the chart, not the news
How does a chart win here? It needed some insanely stupid news for it to move.
CBIH Achieves $2 Billion Valuation Following StoneBridge Advisory Assessment
Newsfile Corp.
Newsfile Corp
Houston, Texas--(Newsfile Corp. - June 17, 2024) - Cannabis Bioscience International Holdings (OTC PINK: CBIH) has been valued at $2 Billion following a rigorous evaluation by StoneBridge Advisory, a leading financial advisory firm based in Los Angeles, California.
StoneBridge's assessment highlights CBIH's formidable market presence, cutting-edge product offerings, and solid business framework. Moreover, this valuation serves as a testament to investor and analyst optimism regarding CBIH's capacity for sustained growth and expansion.
The valuation was reached through a comprehensive review of CBIH's financial metrics, market penetration, industry competition, and strategic planning. Additionally, it took into account the exceptional skill sets within the company. Including securities attorney; corporate attorney, patent attorney, in-house counsel, comptroller with a Magister Scientiarum in Administration, CPA, PCAOB, graphic designer, Master's Degree in Audiovisual Communication and Advertising Content, Ph.D.-level scientists with emphasis on microbiology, medical professionals certified in cancer biology, peritoneal dialysis, pregnancy-related emergency care, as well as board-certified in General medicine and internal medicine, Anti-aging medicine Specialist, Master of Health Care Administration, and Doctorate in Dental Surgery. These experts have contributed to the development of a diversified portfolio of innovative therapies and medical solutions over the past 15 years. Their work addresses gaps in conventional treatments, and provides natural alternatives for widespread health issues globally.
StoneBridge Advisory employed meticulous due diligence and sophisticated financial modeling during the valuation process to guarantee precision and accurately represent the value of CBIH.
John Jones, Treasurer and Director of CBIH, commented on the significance of this valuation, stating: "We have been meticulously reconstructing our company and reinforcing its foundations. Given the promising opportunities we've identified, obtaining a valuation became the next logical step to gauge our progress and plan for future growth." He further noted, "Being positioned in rapidly evolving sectors like medical cannabis, clinical research, and biotechnology, coupled with our unparalleled expertise, positions us uniquely to seize advantageous opportunities that will benefit both our company and shareholders."
This landmark $2 Billion valuation positions CBIH among an elite group of startups and fresher/emerging companies that have achieved such a notable feat. This milestone paves the way for CBIH to pursue strategic alliances, investment opportunities, and ambitious expansion strategies, further cementing its status as a leader in the cannabis bioscience sector.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties, and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file at www.OTCmarkets.com.
For more information contact us at:
(214) 733-0868
ir@cbih.net
Dante Picazo
CEO - CBIH
Website: www.cbih.net
X: www.twitter.com/cbihstock
Instagram: www.instagram.com/CBIHSTOCK
Investor Relations:
East Coast
Peter Nicosia
Bull in Advantage, LLC
Phone: 585-703-6565
Email: Info@BlueHorseshoeStocks.com
West Coast
Zach Logan
Pacific Capital Markets LLC
Phone: 858.864.0011
Email: pacificcapitalmarketsllc@gmail.com
https://images.newsfilecorp.com/files/10188/213088_b92b11ca44633888_logo.jpg
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/213088
SOURCE Cannabis Bioscience International Holdings
https://api.newsfilecorp.com/newsinfo/213088/130
https://www.otcmarkets.com/stock/CBIH/news/story?e&id=2892259
Hey scammer, haven't heard here from you much lately, wonder why
Not to mention the ENDV & MIKP boards..yo where you hiding at? Come face the music Oh, and I'm not a disgruntled "investor" so you can stop floating that narrative. I wouldn't dump a cent into your POS stocks. Just well aware of you & what you & that sh_t-bag Leupold do..
Much truth, bro. Thanks for that
..that part about his son, I'd never heard before. That's going in a dark place right there, damn.. 😣 ruthless, even in my book
He is an utter POS tho, right about that imo. No tears shed for him
Hey, DM me on ST (can't DM here, I'm a freeloader)? ..Interested in comparing a few notes on that operation. Demogod1 on there, too..
😆 haha, this is how ppl react when they realize the truth of the matter is they pissed-away everything on a(n obvious & poorly executed) scam!
Projection.. I mean there's no way around it: You've apparently been scammed.
Call me an idiot for providing the evidence tho
Um ya...bout that..
http://stocktwits.com/Demogod1/message/575849470
..this is pretty concerning tb perfectly h
$CBIH Check it out! https://www.vitabiotech.in/
Vita Biotech Retains CBIH Services for Clinical Studies
"Vita Biotech will act as a financial subsidiary and catalyst for CBIH's data collection trials"
Breakout over 8's appears imminent!
Vita Biotech Retains CBIH Services for Clinical Studies
Newsfile Corp.
Newsfile Corp
Houston, Texas--(Newsfile Corp. - June 5, 2024) - Vita Biotech Research has entered into a significant partnership with Cannabis Bioscience International Holdings (OTC Pink: CBIH), to fund the clinical data collection efforts of CBIH's rigorous data clinical studies, underscoring Vita Biotech's commitment to supporting cutting-edge research and ensuring the highest standards of clinical data integrity.
Through this strategic alliance, Vita Biotech will act as a financial subsidiary and catalyst for CBIH's data collection trials, a vital phase in evaluating the efficacy and safety of its formulations before they reach the market. This accelerated funding is expected to speed up CBIH's progress toward its scientific and commercial goals.
Furthermore, this collaboration allows CBIH to chart a course of its reconstruction process as it facilitates to isolate each medical formulation into a unique legal entity. This risk management strategy aligns with industry practices aimed at simplifying financing and partnerships, streamlining intellectual property and licensing processes.
The choice of Texas as the jurisdiction for patent housing is driven by its business-friendly environment, including favorable judicial precedents, cost-effective litigation, and access to federal courts adept in handling complex cases. Therefore, this calculated maneuver would place CBIH in a strong defensive posture in the event of legal challenges, and it is foreseen to lessen potential legal liabilities of the parent corporation.
The decision to proceed with this collaboration followed medical legal standards to mitigate any potential medical conflicts arising from the studies, upholding ethical standards to maintain credibility and executing CBIH's protocols effectively, which could lead to improved statistical significance.
"The nature of clinical trials and data collection necessitates a cooperative endeavor between different entities, each bringing unique advantages to the table, without compromising the integrity and safety of data management during the trials. This way we take a significant leap forward in both organizations' missions and the enhancement of patient care," says Dr. Jennifer Salguero, PhD in Science specialized in Microbiology from São Paulo Brazil University, and VITA's Director of Clinical Trial Operations.
Overall, this partnership offers a platform for funding CBIH's projects, safeguards both parties from risks related to intellectual property and litigation, and ensures the meticulous and ethical collection of data. CBIH and Vita Biotech look forward to potentially bolster the credibility of our research among leading pharmaceutical companies, paving the way as pioneers in medical cannabis clinical research.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties, and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file at www.OTCmarkets.com.
For more information contact us at:(214) 733-0868
ir@cbih.net
Dante Picazo
CEO - CBIH
Website: www.cbih.net
X: www.twitter.com/cbihstockInstagram: www.instagram.com/CBIHSTOCK
Investor Relations:
East Coast
Peter Nicosia
Bull in Advantage, LLC
Phone: 585-703-6565
Email: Info@BlueHorseshoeStocks.com
West Coast
Zach Logan
Pacific Capital Markets LLC
Phone: 858.864.0011
Email: pacificcapitalmarketsllc@gmail.com
https://images.newsfilecorp.com/files/10188/211751_687e9dd4b440484c_logo.jpg
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/211751
SOURCE Cannabis Bioscience International Holdings
https://api.newsfilecorp.com/newsinfo/211751/130
https://www.otcmarkets.com/stock/CBIH/news/story?e&id=2882133
Don't trust this MORON! Check out his socials & you'll find he runs a SCAM OPERATION, takes shares from companies in exchange for payment: & THEN fake-PUMPS the stocks so he & his buddy Shane Leopold can LIQUIDATE into the unsuspecting!!
This CLOWNSTICK (Jeff Lien) is a POS...
He claimed BRINGING AN ARMY (on his socials) in another stock!!
And is engineering a REVERSE SPLIT so he can clear & liquidate the shares he was paid by the MORON ceo Mark B. Newbauer.
Should they FOLLOW with the R/S I'm going to make sure the SEC/FINRA & other U.S. agencies (this CLOWN Jeff Lien is listed as a REALTOR in Canada & CLEARLY not a successful one: So he trolls the board, claiming he runs a MARKETING company, buying FOLLOWERS across his social platforms & SCAMMING on his DISCORD!! He is a WORLD CLASS POS -- no wonder he lost his son! Prolly a SHIT dad letting his kid get addicted to OPIODS -- he should OFF HIMSELF - imho & make the world a better place. Instead he TROLLS the OTC & preys on the unsuspecting)
PS: NONE of this is unknown information. Do DD on these CornerstoneMarketing CLOWNSTICKS & you'll discover EVERYTHING for yourself... And since they DO NOT OPENLY DISCLOSE being PAID TO PUMP!! I decided I'd share & help people AVOID whatever this SHITSTAINS are pumping/selling.
Because they are NO GOOD at it & have supported one R/S after another!! Essentially WIPING shareholder out!! Investors BEWARE!
Anyone on this board reading this: CONSIDER YOURSELF WARNED!!
JUST THE FACTS PLEASE!!
....
...
..
.
$CBIH Price is cheap and holding up! Potential Merger was announced earlier, when that happens CBIH will be flying up real high! https://www.cbih.net/
BUSINESS DESCRIPTION
The company is dedicated to providing services in all therapeutic areas of clinical research through one of our products: Alpha Research Institute, LLC. a Houston-based Research Unit that offers phase I to phase IV Clinical Research Studies. The Company also operates an international learning platform that provides knowledge about cannabinoids' medical benefits: Pharmacology University. We have been researching medical cannabis uses for more than 15 years, as a result, we have published ebooks, audiobooks, videos, and magazines. Cannabis Bioscience International Holdings will unite both experiences, clinical studies, and knowledge about cannabinoids.
CBIH I've seen this climb, when it climbs it'll go high!
Please be patient. The last couple of days we did nothing but to water the plant, we are under a couple of non circumvent / non disclosure agreements, thank you for your interest. pic.twitter.com/I409GJKzTx
— CBIH (@CBIHstock) March 14, 2024
$CBIH Nice day! Merger and other excellent news are incoming!
$CBIH
Blessed to be part of the greatest medical cannabis company on the OTCMKTS $CBIH - synonym of the future of cannabis medicine https://t.co/Wr3n9RlXD3
— CBIH (@CBIHstock) March 10, 2024
CBIH Announces the Retirement of One Billion Shares
https://ca.finance.yahoo.com/news/cbih-announces-retirement-one-billion-130000159.html
CBIH @CBIHstock
Houston, Texas--(Newsfile Corp. - March 6, 2024) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: $CBIH) announces that Dante Picazo, its chief executive officer, is contributing one billion shares of his common #stock to the Company. These #shares will be retired and have the status of authorized and unissued shares. As a result of this contribution, the number of the Company's outstanding shares has been reduced to approximately 9.4 billion. Since current management assumed control of the Company in 2019, its members have contributed 5.5 billion shares to the Company for no or nominal consideration. The shares have a #market price of approximately $5 million, valued at the closing price of $0.0009 on March 5, 2024. The Company believes that Mr. Picazo's contribution will increase #shareholdervalue
https://ca.finance.yahoo.com/news/cbih-announces-retirement-one-billion-130000159.html
#retirementofshares #stockstowatch #aistocks #MarketNews
5:14 AM · Mar 6, 2024
$CBIH Progress in the making: Possible Merger!
Excellent week! CBIH is talking to a couple of great medical companies about a possible merger.
#CBIH #stock #medicine #medicalcannabis #biotechnology
Brian Cuban Joins Cannabis Bioscience International Holdings as an Advisory Board Member.
https://www.otcmarkets.com/stock/CBIH/news/Brian-Cuban-Joins-Cannabis-Bioscience-International-Holdings-as-an-Advisory-Board-Member?id=431463
@CBIHstock Feb 20
$CBIH Cannabis Bioscience International Holdings, Inc. Announces Engagement of Bull in Advantage as its Investor Relations Firm https://wsj.com/articles/cannabis-bioscience-international-holdings-inc-announces-engagement-of-bull-in-advantage-as-its-investor-relations-firm-57129896 via
@WSJ #Cannabisstocks #Pennystocks #Pharmastocks #Stockfocuslist #Stockstowatch #Pharmaceutical #Biotechnology…
Show more
CBIH Profile. https://www.otcmarkets.com/stock/CBIH/profile
https://www.cbih.net/_files/ugd/172074_675abb627ad4498285cdfa4186ec23e4.pdf
$CBIH https://t.co/Wr3n9RlXD3 pic.twitter.com/L5iF4ngioh
— CBIH (@CBIHstock) March 2, 2024
Yeah, let's do it! CBIH has been a good runner in the past!
Followers
|
200
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
11796
|
Created
|
11/08/09
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |